Research Study

Accumulating Data on the Reproductive Safety of Second-Generation, Atypical Antipsychotics, But Still Not Enough

In a cohort of 351 children exposed to second generation antipsychotic during pregnancy, the risk of major congenital malformations did not differ from a comparison group of non-exposed children.

By MGH Center for Women's Mental Health|2022-06-22T11:48:09-04:00June 21st, 2022|Atypical Antipsychotics, Bipolar Disorder, Medications and Pregnancy, Pregnancy Outcomes, Psychiatric Disorders During Pregnancy, Research Study|0 Comments

Recruiting New Mothers with Postpartum Depression for the Skylark Study

In 2019, brexanolone was introduced by Sage Therapeutics as Zulresso, a novel treatment for postpartum depression. The oral version of this novel antidepressant – SAGE 217 or zuranolone – is now finishing up its Phase [...]

By MGH Center for Women's Mental Health|2021-05-06T15:03:02-04:00February 5th, 2021|Postpartum Psychiatric Disorders, Research Study|0 Comments